Literature DB >> 34290448

Combination treatment in mHSPC.

Rebecca Tregunna1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34290448     DOI: 10.1038/s41585-021-00506-9

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study.

Authors:  Nicholas C Turner; Judith Balmaña; Coralie Poncet; Theodora Goulioti; Konstantinos Tryfonidis; Aafke H Honkoop; Gabriele Zoppoli; Evangelia Razis; Oskar T Johannsson; Marco Colleoni; Andrew N Tutt; William Audeh; Michail Ignatiadis; Audrey Mailliez; Olivier Trédan; Antonino Musolino; Peter Vuylsteke; Maria Jose Juan-Fita; Iain R J Macpherson; Bella Kaufman; Luis Manso; Lori J Goldstein; Susan L Ellard; István Láng; Kai Yu Jen; Virginie Adam; Saskia Litière; John Erban; David A Cameron
Journal:  Clin Cancer Res       Date:  2021-07-22       Impact factor: 12.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.